Announce Date | 07/23/2025 |
EPS Normalized Actual | $3.56 (Beat by $0.17) |
EPS GAAP Actual | $3.56 (Beat by $0.17) |
Revenue Actual | $1.898B |
Revenue Surprise | Beat by $1898M |
Announce Date | 10/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.92273 |
EPS GAAP Estimate | $2.92273 |
Revenue Estimate | $1.7408125B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 19.35 | 25.02 | 18.14354 | 20.13524 | 1 |
Dec 2028 | 16.4 | 29.52 | 16.09221 | 16.81734 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 3.22 | 3.22 | 1.898B | 4.27% | 1898M |
FQ1 2025 (Mar 2025) | 3.47 | 3.47 | 1.924B | 7.17% | 1924M |
FQ4 2024 (Dec 2024) | 2.18 | 2.18 | 1.672B | 98.92% | 1672M |
FQ3 2024 (Sep 2024) | 2.93 | 2.93 | 1.813B | 100% | 1813M |
FQ2 2024 (Jun 2024) | 3.02 | 3.02 | 1.817B | 17.78% | 1817M |
FQ1 2024 (Mar 2024) | 3.16 | 3.16 | 1.786B | 17.69% | 1786M |
FQ4 2023 (Oct 2023) | 0 | 0 | 0.018B | 100% | 18M |
FQ2 2023 (Jun 2023) | 2.05 | 2.05 | 1.494B | 7.56% | 1494M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
2.92273
Consensus Revenue Estimates
1.7408125B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 3.738 | -- | 3.738 | 3.738 | 5 |
FQ3 2027 (Jul 2027) | 3.6227 | -- | 3.6227 | 3.6227 | 5 |
FQ2 2027 (Jun 2027) | 3.649 | -- | 3.48053 | 3.90971 | 5 |
FQ1 2027 (Mar 2027) | 3.8784 | -- | 3.69934 | 4.1555 | 5 |
FQ4 2026 (Oct 2026) | 3.31885 | -- | 3.2551 | 3.3879 | 7 |
FQ3 2026 (Jul 2026) | 3.41861 | -- | 3.35295 | 3.48974 | 4 |
FQ2 2026 (Jun 2026) | 3.90073 | 17.45 | 3.77801 | 4.0003 | 4 |
FQ1 2026 (Mar 2026) | 3.94245 | 11.98 | 3.81842 | 4.04309 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 2.17B | -- | 2.17B | 2.17B | 9 |
FQ3 2027 (Jul 2027) | 2.14B | -- | 2.14B | 2.14B | 6 |
FQ2 2027 (Jun 2027) | 2.15B | -- | 2.07B | 2.27B | 5 |
FQ1 2027 (Mar 2027) | 2.12B | -- | 2.05B | 2.24B | 5 |
FQ4 2026 (Oct 2026) | 1.87B | -- | 1.85B | 1.9B | 8 |
FQ3 2026 (Jul 2026) | 1.89B | -- | 1.86B | 1.92B | 5 |
FQ2 2026 (Jun 2026) | 2.01B | 5.65 | 1.96B | 2.05B | 5 |
FQ1 2026 (Mar 2026) | 2B | 3.74 | 1.95B | 2.04B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 3.22 | 3.22 | 100% | |
FQ1 2025 (Mar 2025) | 3.47 | 3.47 | 100% | |
FQ4 2024 (Dec 2024) | 2.18 | 2.18 | 100% | |
FQ3 2024 (Sep 2024) | 2.93 | 2.93 | 100% | |
FQ2 2024 (Jun 2024) | 3.02 | 3.02 | 100% | |
FQ1 2024 (Mar 2024) | 3.16 | 3.16 | 100% | |
FQ4 2023 (Oct 2023) | 0 | 0 | NAN% | |
FQ2 2023 (Jun 2023) | 2.05 | 2.05 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $1.9B | $1898M | 100% |
FQ1 2025 (Mar 2025) | $0B | $1.92B | $1924M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.67B | $1672M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.81B | $1813M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.82B | $1817M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.79B | $1786M | 100% |
FQ4 2023 (Oct 2023) | $0B | $0.02B | $18M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.49B | $1494M | 100% |